Clinical Trial

Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2025 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are: * Is the new quantification method superior with respect to the method currently used in the clinic? * Does the new quantification method provide accurate assessment of the sugar consumption of tumours? Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-12-08; most recent amendment 2025-01-28.
Status change: Not Yet Recruiting → Recruiting 2023-07-04
Trial Details
NCT Number NCT05654675
Lead Sponsor Academisch Ziekenhuis Maastricht
Conditions Lung Cancer, Lymphoma
Enrollment 30 participants
Start Date 2024-01-15
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-29